BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, February 17, 2026
Home » Topics » Financings

Financings
Financings RSS Feed RSS

Newborn feet

UK newborn genome project targeting rare disease backed by £105M

Dec. 14, 2022
By Nuala Moran
The U.K. is taking the next step in applying genomics to health care with the launch of a £105 million (US$130 million) project that will sequence the whole genomes of 100,000 healthy newborn babies to detect rare genetic conditions.
Read More

Financings for Dec. 14, 2022

Dec. 14, 2022
Med-tech firms raising money in public or private financings, including: Brightspec.
Read More

Financings for Dec. 14, 2022

Dec. 14, 2022
Biopharmas raising money in public or private financings, including: Alpha-9, Carocell, Etcembly, Montai, NLS, Prothena, Psyence.
Read More

Financings for Dec. 13, 2022

Dec. 13, 2022
Med-tech firms raising money in public or private financings, including: Efemoral Medical, Histosonics.
Read More

Financings for Dec. 13, 2022

Dec. 13, 2022
Biopharmas in Asia-Pacific raising money in public or private financings: Biomebank, Vaxxas.
Read More

Financings for Dec. 13, 2022

Dec. 13, 2022
Biopharmas raising money in public or private financings, including: Amphista, Contrafect, Peroxitech, Tellus.
Read More

Olive seeking $10M in A round for urine analysis system

Dec. 12, 2022
By Nuala Moran
Olive Diagnostics Pvt. Ltd. is looking to raise $10 million in a series A funding round to extend sales and marketing activities, after getting CE approval for its urine analysis device that mounts on any toilet. Among other parameters the device, Olive KG, can measure red blood cells, proteins, nitrates, pH levels volume, pressure and frequency of urination.
Read More

Financings for Dec. 12, 2022

Dec. 12, 2022
Med-tech firms raising money in public or private financings, including: Monarch Medical Technologies, Semler Scientific.
Read More

Financings for Dec. 12, 2022

Dec. 12, 2022
Biopharmas raising money in public or private financings, including: Adma, Aptose, Black Diamond, Celcuity, Clene, Immunitybio, Inventiva.
Read More

Financings for Dec. 9, 2022

Dec. 9, 2022
Med-tech firms raising money in public or private financings, including: Sonde Health.
Read More
Previous 1 2 … 301 302 303 304 305 306 307 308 309 … 652 653 Next

Popular Stories

  • Today's news in brief

    BioWorld
  • Illustration of SCAN in Parkinson’s vs healthy subcortex

    SCAN is core circuit affected in Parkinson’s disease

    BioWorld Science
    Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • Woman and 3D brain

    Astellas’ ASP-2246 shows promise in stroke management

    BioWorld Science
    Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing